Vacuolar ATPase ‘a2’ isoform exhibits distinct cell surface accumulation and modulates matrix metalloproteinase activity in ovarian cancer
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
// Arpita Kulshrestha 1 , Gajendra K. Katara 1 , Safaa Ibrahim 1, 2 , Sahithi Pamarthy 1 , Mukesh K. Jaiswal 1 , Alice Gilman Sachs 1 , Kenneth D. Beaman 1 1 Department of Microbiology and Immunology, Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA 2 Department of Microbiology and Immunology, Faculty of Pharmacy, Cairo University, Egypt Correspondence to: Kenneth D. Beaman, e-mail: kenneth.beaman@rosalindfranklin.edu Keywords: Vacuolar ATPase, a2 isoform, ovarian cancer, invasion, cortactin, MMP Received: September 19, 2014 Accepted: December 14, 2014 Published: January 21, 2015 ABSTRACT Tumor associated vacuolar H+-ATPases (V-ATPases) are multi-subunit proton pumps that acidify tumor microenvironment, thereby promoting tumor invasion. Subunit ‘a’ of its V0 domain is the major pH sensing unit that additionally controls sub-cellular targeting of V-ATPase and exists in four different isoforms. Our study reports an elevated expression of the V-ATPase-V0a2 isoform in ovarian cancer(OVCA) tissues and cell lines(A2780, SKOV-3 and TOV-112D). Among all V0’a’ isoforms, V0a2 exhibited abundant expression on OVCA cell surface while normal ovarian epithelia did not. Sub-cellular distribution of V-ATPase-V0a2 confirmed its localization on plasma-membrane, where it was also co-associated with cortactin, an F-actin stabilizing protein at leading edges of cancer cells. Additionally, V0a2 was also localized in early and late endosomal compartments that are sites for modulations of several signaling pathways in cancer. Targeted inhibition of V-ATPase-V0a2 suppressed matrix metalloproteinase activity(MMP-9 & MMP-2) in OVCA cells. In conclusion, V-ATPase-V0a2 isoform is abundantly expressed on ovarian tumor cell surface in association with invasion assembly related proteins and plays critical role in tumor invasion by modulating the activity of matrix-degrading proteases. This study highlights for the first time, the importance of V-ATPase-V0a2 isoform as a distinct biomarker and possible therapeutic target for treatment of ovarian carcinoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The vacuolar (H+)-ATPases — nature's most versatile proton pumps
Nishi, T., & Forgac, M. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm729 · Cited by 1,197
Cited by
Recent Insights into the Structure, Regulation, and Function of the V-ATPases
Cotter, K., Stransky, L., McGuire, C., & Forgac, M. (2015) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.08.005 · Cited by 337
The Function of V-ATPases in Cancer
Stransky, L., Cotter, K., & Forgac, M. (2016) · Physiological Reviews · doi:10.1152/physrev.00035.2015 · Cited by 276
Iron and thiol redox signaling in cancer: an exquisite balance to escape ferroptosis
Toyokuni, S., Ito, F., Yamashita, K., Okazaki, Y., & Akatsuka, S. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.04.024 · Cited by 252
“This constitutes a unique acidic environment that favors the secretion of cytokines and growth factors that initiate angiogenesis and tissue repair [218], in which a2 V-ATPase appears to play a role [219,220].”
Mustaly-Kalimi, S., Gallegos, W., Marr, R. A., Gilman-Sachs, A., Peterson, D. A., Sekler, I., & Stutzmann, G. E. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2211999119 · Cited by 55
“Beaman and Gilman-Sachs (46, 47); LC3B (1:500; Abcam 48394)] overnight at 4C on a platform rocker.”
InfluentialSelf-citation
Metadata
- Authors
- Kulshrestha, A., Katara, G. K., Ibrahim, S., Pamarthy, S., Jaiswal, M. K., Sachs, A. G., & Beaman, K. D.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2015-01-21
- Volume
- 6
- Issue
- 6
- Pages
- 3797-3810
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W1865575659
- Cited by
- 65
- References
- 1
- FWCI
- 3.60
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.